Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024

Kun Huang1,2, Ye He1,3, Hao Wan1

  • 1Department of Human Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China.

Frontiers in Immunology
|October 30, 2024
PubMed
Abstract

Insights

This study analyzes global research trends on Transforming growth factor-beta-activation kinase 1 (TAK1) in regulated cell death (RCD). Emerging hotspots include apoptosis, NF-κB, inflammation, autophagy, and TNFα, guiding future investigations.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Regulated cell death (RCD) is crucial for development, tissue repair, and cancer.
  • Transforming growth factor-beta-activation kinase 1 (TAK1) is a key kinase involved in inflammatory responses and multiple cell death pathways.
  • TAK1's role at the intersection of apoptosis, necroptosis, pyroptosis, and PANoptosis has been a focus of recent research.

Purpose of the Study:

  • To conduct a bibliometric and visualized analysis of global research trends and hotspots concerning TAK1's role in RCD.
  • To identify key research institutions, prolific authors, and influential journals in the field.
  • To map the evolution of research topics and identify emerging frontiers in TAK1-mediated RCD.

Main Methods:

  • Bibliometric analysis of 801 articles retrieved from the Web of Science Core Collection.
  • Utilized VOSviewer for co-occurrence and co-cited analysis.
  • Employed CiteSpace for dual-map overlays, citation bursts, and keyword timeline analysis.

Main Results:

  • Consistent publication growth observed from 1999 to 2024, with 801 articles from 46 countries.
  • Osaka University identified as a leading institution, with Jun Tsuji as a highly cited author.
  • Key research hotspots include apoptosis, NF-κB, inflammation, autophagy, and TNFα.

Conclusions:

  • This is the first bibliometric study to comprehensively map global research on TAK1 in RCD.
  • The findings provide a visualized overview of research frontiers and guide future investigations into molecular mechanisms and therapeutic strategies.
  • Highlights the dynamic and expanding research landscape of TAK1 in diverse RCD pathways.